Both in Biotechnology
Maze Therapeutics vs Vir Biotechnology
Over the past year MAZE returned +0.3% and VIR returned +107.1%; their daily moves had a correlation of 0.26.
MAZE +0.3% VIR +107.1%Growth of $1, one year, split-adjusted
| Metric | MAZE | VIR |
|---|---|---|
| Price | $32.25 | $11.22 |
| Market cap | $1.79B | $1.90B |
| Today | +6.19% | +2.00% |
| 1 month | +22.0% | −4.8% |
| 6 months | +21.4% | +12.1% |
| Year to date | −22.2% | +86.1% |
| 1 year | −2.0% | +88.3% |
| Revenue growth (YoY) | — | +19582.5% |
| Gross margin | — | 100.0% |
| Net margin | — | 33.5% |
| P/E (TTM) | — | — |
| Price / sales | 89.6× | 6.3× |
| Net cash | $372.1M | $532.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.4% | 51.5% |
| Short % of float | 18.8% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).